UnitedHealth Group Incorporated Company Profile (NYSE:UNH)

About UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group Incorporated logoUnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum. UnitedHealthcare provides healthcare benefits to an array of customers and markets, and includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State, and UnitedHealthcare Global businesses. Optum is a health services business serving the healthcare marketplace, including payers, care providers, employers, governments, life sciences companies and consumers, through its OptumHealth, OptumInsight and OptumRx businesses. OptumInsight provides services, technology and healthcare solutions to participants in the healthcare industry. OptumRx provides retail network contracting, purchasing and clinical solutions.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Managed Health Care
  • Sub-Industry: Managed Health Care
  • Symbol: NYSE:UNH
  • CUSIP: 91324P10
  • Web: www.unitedhealthgroup.com
  • Market Cap: $205.21 billion
  • Outstanding Shares: 989,000,000
Average Prices:
  • 50 Day Moving Avg: $197.42
  • 200 Day Moving Avg: $185.93
  • 52 Week Range: $136.22 - $208.21
  • Trailing P/E Ratio: 23.56
  • Foreward P/E Ratio: 19.07
  • P/E Growth: 1.37
Sales & Book Value:
  • Annual Revenue: $196.63 billion
  • Price / Sales: 1.04
  • Book Value: $47.84 per share
  • Price / Book: 4.34
  • Annual Dividend: $3.00
  • Dividend Yield: 1.5%
  • EBITDA: $16.14 billion
  • Net Margins: 4.50%
  • Return on Equity: 21.52%
  • Return on Assets: 6.99%
  • Debt-to-Equity Ratio: 0.52%
  • Current Ratio: 0.70%
  • Quick Ratio: 0.72%
  • Average Volume: 2.87 million shs.
  • Beta: 0.63
  • Short Ratio: 3.35

Frequently Asked Questions for UnitedHealth Group Incorporated (NYSE:UNH)

What is UnitedHealth Group Incorporated's stock symbol?

UnitedHealth Group Incorporated trades on the New York Stock Exchange (NYSE) under the ticker symbol "UNH."

How often does UnitedHealth Group Incorporated pay dividends? What is the dividend yield for UnitedHealth Group Incorporated?

UnitedHealth Group Incorporated announced a quarterly dividend on Wednesday, August 16th. Stockholders of record on Friday, September 8th will be paid a dividend of $0.75 per share on Tuesday, September 19th. This represents a $3.00 annualized dividend and a dividend yield of 1.45%. The ex-dividend date is Thursday, September 7th. View UnitedHealth Group Incorporated's Dividend History.

How were UnitedHealth Group Incorporated's earnings last quarter?

UnitedHealth Group Incorporated (NYSE:UNH) posted its quarterly earnings data on Tuesday, October, 17th. The company reported $2.66 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $2.57 by $0.09. The firm earned $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group Incorporated had a return on equity of 21.52% and a net margin of 4.50%. UnitedHealth Group Incorporated's revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm posted $2.17 earnings per share. View UnitedHealth Group Incorporated's Earnings History.

When will UnitedHealth Group Incorporated make its next earnings announcement?

UnitedHealth Group Incorporated is scheduled to release their next quarterly earnings announcement on Monday, January, 15th 2018. View Earnings Estimates for UnitedHealth Group Incorporated.

What guidance has UnitedHealth Group Incorporated issued on next quarter's earnings?

UnitedHealth Group Incorporated updated its FY17 earnings guidance on Tuesday, October, 17th. The company provided earnings per share (EPS) guidance of $10.00 for the period, compared to the Thomson Reuters consensus estimate of $9.86.

Where is UnitedHealth Group Incorporated's stock going? Where will UnitedHealth Group Incorporated's stock price be in 2017?

22 brokers have issued 12 month target prices for UnitedHealth Group Incorporated's shares. Their predictions range from $178.00 to $250.00. On average, they expect UnitedHealth Group Incorporated's share price to reach $216.57 in the next twelve months. View Analyst Ratings for UnitedHealth Group Incorporated.

What are analysts saying about UnitedHealth Group Incorporated stock?

Here are some recent quotes from research analysts about UnitedHealth Group Incorporated stock:

  • 1. According to Zacks Investment Research, "Shares of UnitedHealth Group has outperformed the industry in last one year. Its  robust Government business and continued strong growth at Optum are driving long-term growth. Its international business, growing membership and strong capital position are the other positives. In the most recently reported quarter, the company reported better-than-expected earnings, driven by an increase in revenues and membership. Encouraged by its impressive first-half earnings, the company raised the 2017 guidance. Nevertheless, the company has reduced its exposure to the troubled public exchange business. Though this move will shield it from losses in this business, premium revenues are likely to be affected. Charges related to Penn Treaty are also causes for concern." (10/10/2017)
  • 2. Cantor Fitzgerald analysts commented, "Expect 2Q17 performance to be solid. We estimate 2Q17 revenue to be $49.4 billion (+6.2% y/y) vs. FactSet consensus of $50.0 billion. We expect revenue growth to be broad-based, with the strongest growth in Medicare and Medicaid. We expect continued benefits from its reduced exposure to ACA individual markets in 2017. We project medical cost ratio to improve to 82.1% (-30bps q/ q) primarily due to reduced exposure to individual markets. We estimate 2Q17 EPS of $2.40 vs. FactSet consensus of $2.38. We expect total membership to grow by 2.9% y/y to about 49.35 million members." (7/7/2017)
  • 3. Credit Suisse Group analysts commented, "With phase I data for Radius’s SERD RAD1901 coming at SABCS next week, we wanted to share our thoughts heading into the data. Our top incoming question has been how many responses will we see?" and while management comments have been limited to the term multiple responses" our base case heading into the meeting is that we see responses in 3 of the 23 patients for whom we expect to see data (n=20 in expansion cohort and n=3 in the FES-PET study). To the extent this data looks encouraging and supports continued development, we believe the Street could begin to ascribe more value to the asset, which in our DCF accounts for $12/share of value (25% prob of $750mm peak sales). Beyond SABCS, we continue to expect approval for lead asset abaloparatide (osteoporosis) on March 30 and a positive CHMP opinion late-2016/early-2017." (11/30/2016)

Who are some of UnitedHealth Group Incorporated's key competitors?

Who are UnitedHealth Group Incorporated's key executives?

UnitedHealth Group Incorporated's management team includes the folowing people:

  • Stephen J. Hemsley, Executive Chairman of the Board
  • David Scott Wichmann, Chief Executive Officer, Director
  • John F. Rex, Chief Financial Officer, Executive Vice President
  • Larry C. Renfro, Vice Chairman - UnitedHealth Group, Chief Executive Officer - Optum
  • Marianne D. Short, Executive Vice President, Chief Legal Officer
  • D. Ellen Wilson, Executive Vice President - Human Capital
  • Thomas E. Roos, Senior Vice President, Chief Accounting Officer
  • Richard T. Burke Sr., Lead Independent Director
  • William C. Ballard Jr., Independent Director
  • Timothy P. Flynn, Independent Director

Who owns UnitedHealth Group Incorporated stock?

UnitedHealth Group Incorporated's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Sanders Capital LLC (0.32%), PGGM Investments (0.11%), APG Asset Management N.V. (0.09%), Focused Investors LLC (0.05%), Robeco Institutional Asset Management B.V. (0.04%) and Shell Asset Management Co. (0.04%). Company insiders that own UnitedHealth Group Incorporated stock include D Ellen Wilson, Gail R Wilensky, Kenneth Irwin Shine, Larry C Renfro, Michele J Hooper, Richard T Burke, Stephen J Hemsley, Thomas E Roos, William C Ballard Jr and William C Ballard, Jr. View Institutional Ownership Trends for UnitedHealth Group Incorporated.

Who sold UnitedHealth Group Incorporated stock? Who is selling UnitedHealth Group Incorporated stock?

UnitedHealth Group Incorporated's stock was sold by a variety of institutional investors in the last quarter, including Sit Investment Associates Inc., State Treasurer State of Michigan, Robeco Institutional Asset Management B.V., Asset Advisors Corp, Focused Investors LLC, Inverness Counsel LLC NY, Meeder Asset Management Inc. and APG Asset Management N.V.. Company insiders that have sold UnitedHealth Group Incorporated stock in the last year include D Ellen Wilson, Gail R Wilensky, Kenneth Irwin Shine, Larry C Renfro, Michele J Hooper, Richard T Burke, Thomas E Roos and William C Ballard Jr. View Insider Buying and Selling for UnitedHealth Group Incorporated.

Who bought UnitedHealth Group Incorporated stock? Who is buying UnitedHealth Group Incorporated stock?

UnitedHealth Group Incorporated's stock was bought by a variety of institutional investors in the last quarter, including Shell Asset Management Co., Sanders Capital LLC, PGGM Investments, Howe & Rusling Inc., Carnick & Kubik Group LLC, Assenagon Asset Management S.A., Mutual of America Capital Management LLC and Wealth Enhancement Advisory Services LLC. View Insider Buying and Selling for UnitedHealth Group Incorporated.

How do I buy UnitedHealth Group Incorporated stock?

Shares of UnitedHealth Group Incorporated can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is UnitedHealth Group Incorporated's stock price today?

One share of UnitedHealth Group Incorporated stock can currently be purchased for approximately $207.49.

MarketBeat Community Rating for UnitedHealth Group Incorporated (NYSE UNH)
Community Ranking:  3.8 out of 5 (star star star)
Outperform Votes:  1,001 (Vote Outperform)
Underperform Votes:  306 (Vote Underperform)
Total Votes:  1,307
MarketBeat's community ratings are surveys of what our community members think about UnitedHealth Group Incorporated and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for UnitedHealth Group Incorporated (NYSE:UNH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 22 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $216.57 (4.38% upside)
Consensus Price Target History for UnitedHealth Group Incorporated (NYSE:UNH)
Price Target History for UnitedHealth Group Incorporated (NYSE:UNH)
Analysts' Ratings History for UnitedHealth Group Incorporated (NYSE:UNH)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/19/2017ArgusBoost Price TargetBuy$215.00 -> $230.00N/AView Rating Details
10/19/2017Sanford C. BernsteinReiterated RatingOutperform$210.00 -> $219.00N/AView Rating Details
10/18/2017Oppenheimer Holdings, Inc.Boost Price TargetBuy -> Outperform$215.00 -> $205.00N/AView Rating Details
10/18/2017Bank of America CorporationBoost Price TargetBuy$230.00 -> $240.00N/AView Rating Details
10/18/2017Citigroup Inc.Boost Price TargetBuy$213.00 -> $235.00N/AView Rating Details
10/18/2017Morgan StanleyBoost Price TargetOverweight$215.00 -> $235.00N/AView Rating Details
10/18/2017Leerink SwannReiterated RatingBuy$225.00 -> $240.00N/AView Rating Details
10/18/2017Cantor FitzgeraldBoost Price TargetOverweight$225.00N/AView Rating Details
10/17/2017Piper Jaffray CompaniesBoost Price TargetOverweight$228.00N/AView Rating Details
10/16/2017BMO Capital MarketsInitiated CoverageOutperform$250.00 -> $250.00N/AView Rating Details
10/13/2017Jefferies Group LLCBoost Price TargetBuy$215.00 -> $225.00N/AView Rating Details
8/11/2017Cowen and CompanyReiterated RatingOutperform$175.00 -> $220.00LowView Rating Details
7/20/2017Royal Bank Of CanadaReiterated RatingBuy$212.00LowView Rating Details
7/19/2017Barclays PLCBoost Price TargetOverweight$200.00 -> $217.00LowView Rating Details
7/18/2017MizuhoSet Price TargetBuy -> Buy$200.00 -> $235.00LowView Rating Details
7/13/2017Deutsche Bank AGBoost Price TargetBuy$187.00 -> $197.00LowView Rating Details
7/13/2017Credit Suisse GroupReiterated RatingOutperform$195.00 -> $200.00LowView Rating Details
6/28/2017Stifel NicolausReiterated RatingBuy$185.00LowView Rating Details
4/24/2017CIBCBoost Price TargetOutperform$186.00 -> $187.00LowView Rating Details
4/19/2017Evercore ISIReiterated RatingOutperform$185.00LowView Rating Details
2/21/2017Wells Fargo & CompanyReiterated RatingOutperformN/AView Rating Details
11/30/2016J P Morgan Chase & CoBoost Price TargetOverweight$170.00 -> $178.00N/AView Rating Details
7/20/2016FBR & CoReiterated RatingOutperform$145.00 -> $155.00N/AView Rating Details
7/19/2016WedbushReiterated RatingOutperform$165.00N/AView Rating Details
6/28/2016Wolfe ResearchInitiated CoverageOutperform$172.00N/AView Rating Details
4/8/2016Cleveland ResearchInitiated CoverageBuy$155.00N/AView Rating Details
2/9/2016Goldman Sachs Group IncLower Price Target$130.00 -> $124.00N/AView Rating Details
12/2/2015Susquehanna Bancshares IncReiterated RatingPositive$150.00N/AView Rating Details
11/20/2015Raymond James Financial, Inc.Lower Price TargetStrong-Buy$146.00 -> $140.00N/AView Rating Details
(Data available from 10/21/2015 forward)


Earnings History for UnitedHealth Group Incorporated (NYSE:UNH)
Earnings by Quarter for UnitedHealth Group Incorporated (NYSE:UNH)
Earnings History by Quarter for UnitedHealth Group Incorporated (NYSE UNH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/15/2018$2.50N/AView Earnings Details
10/17/2017Q3 2017$2.57$2.66$50.38 billion$50.32 billionViewN/AView Earnings Details
7/18/2017Q2 2017$2.38$2.46$49.97 billion$50.05 billionViewN/AView Earnings Details
4/18/2017Q1 2017$2.17$2.37$48.21 billion$48.72 billionViewN/AView Earnings Details
1/17/2017Q416$2.07$2.11$47.12 billion$47.50 billionViewN/AView Earnings Details
10/18/2016Q316$2.08$2.17$46.09 billion$46.30 billionViewListenView Earnings Details
7/19/2016Q216$1.89$1.96$45.05 billion$46.50 billionViewListenView Earnings Details
4/19/2016Q116$1.72$1.81$43.96 billion$44.50 billionViewListenView Earnings Details
1/19/2016Q415$1.38$1.40$43.26 billion$43.60 billionViewListenView Earnings Details
10/15/2015Q315$1.64$1.65$40.18 billion$41.50 billionViewListenView Earnings Details
7/16/2015Q215$1.59$1.64$35.66 billion$36.30 billionViewListenView Earnings Details
4/16/2015Q115$1.33$1.46$34.54 billion$35.80 billionViewN/AView Earnings Details
1/21/2015Q414$1.50$1.55$33.11 billion$33.40 billionViewN/AView Earnings Details
10/16/2014Q314$1.53$1.63$32.70 billion$32.80 billionViewListenView Earnings Details
7/17/2014Q214$1.26$1.42$32.01 billion$32.60 billionViewN/AView Earnings Details
4/17/2014Q114$1.09$1.10$32.03 billion$31.70 billionViewN/AView Earnings Details
1/15/2014Q413$1.40$1.41$31.06 billion$31.10 billionViewN/AView Earnings Details
10/17/2013Q313$1.52$1.53$30.80 billion$60.60 billionViewN/AView Earnings Details
7/18/2013Q2 2013$1.25$1.40$30.48 billion$30.40 billionViewN/AView Earnings Details
4/18/2013Q1 2013$1.14$1.16$30.49 billion$30.30 billionViewListenView Earnings Details
1/17/2013Q4 2012$1.19$1.20$28.13 billion$28.77 billionViewListenView Earnings Details
10/16/2012$1.34$1.50ViewN/AView Earnings Details
7/19/2012$1.19$1.27ViewN/AView Earnings Details
4/19/2012$1.17$1.31ViewN/AView Earnings Details
1/19/2012$1.03$1.17ViewN/AView Earnings Details
10/18/2011$1.12$1.17ViewN/AView Earnings Details
7/19/2011$0.98$1.16ViewN/AView Earnings Details
4/21/2011$0.89$1.22ViewN/AView Earnings Details
1/20/2011$0.84$0.94ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for UnitedHealth Group Incorporated (NYSE:UNH)
2017 EPS Consensus Estimate: $9.47
2018 EPS Consensus Estimate: $10.84
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.01$2.19$2.13
Q2 20174$2.15$2.39$2.33
Q3 20174$2.45$2.61$2.54
Q4 20174$2.40$2.51$2.48
Q1 20182$2.49$2.68$2.59
Q2 20182$2.67$2.67$2.67
Q3 20182$2.88$2.88$2.88
Q4 20182$2.63$2.77$2.70
(Data provided by Zacks Investment Research)


Current Dividend Information for UnitedHealth Group Incorporated (NYSE:UNH)
Most Recent Dividend:9/19/2017
Annual Dividend:$3.00
Dividend Yield:1.45%
Dividend Growth:31.20% (3 Year Average)
Payout Ratio:33.26% (Trailing 12 Months of Earnings)
30.12% (Based on This Year's Estimates)
27.57% (Based on Next Year's Estimates)
Track Record:7 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for UnitedHealth Group Incorporated (NYSE:UNH)

Dividend History by Quarter for UnitedHealth Group Incorporated (NYSE UNH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for UnitedHealth Group Incorporated (NYSE:UNH)
Insider Ownership Percentage: 0.89%
Institutional Ownership Percentage: 86.11%
Insider Trades by Quarter for UnitedHealth Group Incorporated (NYSE:UNH)
Institutional Ownership by Quarter for UnitedHealth Group Incorporated (NYSE:UNH)
Insider Trades by Quarter for UnitedHealth Group Incorporated (NYSE:UNH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/19/2017Thomas E RoosInsiderSell975$205.47$200,333.25View SEC Filing  
9/15/2017Larry C RenfroInsiderSell50,574$198.11$10,019,215.14View SEC Filing  
9/5/2017Gail R WilenskyDirectorSell5,600$199.49$1,117,144.00View SEC Filing  
8/21/2017Richard T BurkeDirectorSell15,000$191.71$2,875,650.00View SEC Filing  
8/3/2017William C Ballard JrDirectorSell5,000$193.98$969,900.00View SEC Filing  
6/7/2017William C Ballard JrDirectorSell5,000$182.64$913,200.00View SEC Filing  
6/2/2017Gail R WilenskyDirectorSell5,540$178.74$990,219.60View SEC Filing  
4/20/2017William C Ballard JrDirectorSell5,000$170.47$852,350.00View SEC Filing  
4/19/2017D Ellen WilsonEVPSell14,000$170.54$2,387,560.00View SEC Filing  
4/19/2017Kenneth Irwin ShineDirectorSell838$169.12$141,722.56View SEC Filing  
3/16/2017Michele J HooperDirectorSell15,000$170.89$2,563,350.00View SEC Filing  
2/23/2017Gail R WilenskyDirectorSell5,310$162.31$861,866.10View SEC Filing  
2/14/2017William C Ballard JrDirectorSell5,000$162.68$813,400.00View SEC Filing  
1/31/2017Richard T BurkeDirectorSell10,000$161.68$1,616,800.00View SEC Filing  
12/15/2016Richard T BurkeDirectorSell15,000$159.80$2,397,000.00View SEC Filing  
12/8/2016Richard T BurkeDirectorSell45,000$158.66$7,139,700.00View SEC Filing  
11/17/2016Gail R WilenskyDirectorSell5,460$150.55$822,003.00View SEC Filing  
10/21/2016D Ellen WilsonEVPSell14,365$144.18$2,071,145.70View SEC Filing  
10/21/2016Kenneth Irwin ShineDirectorSell325$144.99$47,121.75View SEC Filing  
9/7/2016Richard T BurkeDirectorSell40,000$135.31$5,412,400.00View SEC Filing  
6/16/2016William C Ballard JrDirectorSell5,000$138.58$692,900.00View SEC Filing  
6/10/2016Gail R WilenskyDirectorSell5,500$139.80$768,900.00View SEC Filing  
4/20/2016William C Ballard JrDirectorSell5,000$134.87$674,350.00View SEC Filing  
3/14/2016Gail R WilenskyDirectorSell5,420$124.51$674,844.20View SEC Filing  
3/7/2016D Ellen WilsonEVPSell4,113$121.51$499,770.63View SEC Filing  
2/16/2016Gail R. WilenskyDirectorSell8,530$114.00$972,420.00View SEC Filing  
2/4/2016Richard T BurkeDirectorSell50,000$113.69$5,684,500.00View SEC Filing  
2/1/2016William C. Ballard, Jr.DirectorSell8,000$114.93$919,440.00View SEC Filing  
1/29/2016Stephen J. HemsleyinsiderSell200,000$113.30$22,660,000.00View SEC Filing  
11/23/2015William C. Ballard, Jr.DirectorSell10,000$114.13$1,141,300.00View SEC Filing  
9/11/2015Richard T. BurkeDirectorSell50,000$117.62$5,881,000.00View SEC Filing  
6/11/2015Gail R WilenskyDirectorSell20,620$118.97$2,453,161.40View SEC Filing  
4/20/2015D Ellen WilsonEVPSell3,300$119.48$394,284.00View SEC Filing  
3/18/2015William C Ballard JrDirectorSell10,000$120.48$1,204,800.00View SEC Filing  
1/26/2015William C Ballard JrDirectorSell10,000$111.66$1,116,600.00View SEC Filing  
1/22/2015Gail R WilenskyDirectorSell20,850$109.75$2,288,287.50View SEC Filing  
9/17/2014Richard T BurkeDirectorSell100,000$87.03$8,703,000.00View SEC Filing  
9/16/2014Douglas W LeatherdaleDirectorSell15,800$87.21$1,377,918.00View SEC Filing  
8/26/2014Gail R WilenskyDirectorSell10,400$85.00$884,000.00View SEC Filing  
5/9/2014William Ballard, Jr.DirectorSell10,000$76.82$768,200.00View SEC Filing  
4/24/2014Rodger LawsonDirectorBuy1,000$76.21$76,210.00View SEC Filing  
3/18/2014William Ballard, Jr.DirectorSell10,000$77.87$778,700.00View SEC Filing  
2/28/2014Gail BoudreauxCEOSell90,392$76.04$6,873,407.68View SEC Filing  
2/20/2014Eric RangenSVPSell24,825$73.60$1,827,120.00View SEC Filing  
2/18/2014Gail WilenskyDirectorSell21,100$74.03$1,562,033.00View SEC Filing  
1/21/2014William Ballard, Jr.DirectorSell10,000$73.05$730,500.00View SEC Filing  
12/5/2013Douglas LeatherdaleDirectorSell46,240$72.89$3,370,433.60View SEC Filing  
9/11/2013Douglas W LeatherdaleDirectorSell15,000$74.98$1,124,700.00View SEC Filing  
9/6/2013Douglas W LeatherdaleDirectorSell15,000$74.36$1,115,400.00View SEC Filing  
8/19/2013Rodger LawsonDirectorBuy1,000$71.64$71,640.00View SEC Filing  
7/24/2013Richard T BurkeDirectorSell100,000$72.94$7,294,000.00View SEC Filing  
7/23/2013William C Ballard JrDirectorSell10,000$72.61$726,100.00View SEC Filing  
7/19/2013Douglas W LeatherdaleDirectorSell10,000$71.17$711,700.00View SEC Filing  
6/10/2013William C Ballard JrDirectorSell10,000$63.83$638,300.00View SEC Filing  
5/10/2013Lori SweereEVPSell6,000$62.76$376,560.00View SEC Filing  
5/9/2013Lori SweereEVPSell23,866$61.35$1,464,179.10View SEC Filing  
5/7/2013Eric S RangenSVPSell19,925$60.98$1,215,026.50View SEC Filing  
1/18/2013Rodger A LawsonDirectorBuy2,000$54.42$108,840.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for UnitedHealth Group Incorporated (NYSE:UNH)
Latest Headlines for UnitedHealth Group Incorporated (NYSE:UNH)
Loading headlines, please wait.



UnitedHealth Group Incorporated (UNH) Chart for Saturday, October, 21, 2017

This page was last updated on 10/21/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.